
our work passion

Situation: Glaukos was developing a new technology: the iStent. In a sea of pharmacological options, Glaukos needed to raise awareness among ophthalmologists of this standard-changing technology.
Key Insight: Present glaucoma specialists and cataract surgeons with a new view of the safety and efficacy of current treatments.

